Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive Bacteria

There is a drought of new antibacterial compounds that exploit novel targets. Thioredoxin reductase (TrxR) from the Gram-positive bacterial antioxidant thioredoxin system has emerged from multiple screening efforts as a potential target for auranofin, ebselen, shikonin, and allicin. Auranofin serves...

Descripción completa

Detalles Bibliográficos
Autores principales: Felix, LewisOscar, Mylonakis, Eleftherios, Fuchs, Beth Burgwyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085250/
https://www.ncbi.nlm.nih.gov/pubmed/33936021
http://dx.doi.org/10.3389/fmicb.2021.663481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085250/
https://www.ncbi.nlm.nih.gov/pubmed/33936021
http://dx.doi.org/10.3389/fmicb.2021.663481

Ejemplares similares